Dr. Annette Stemhagen, SVP & Chief Scientific Officer, speaks about Pregnancy Exposure Registries (PERs) and why partnering with an experienced team is so vital.
August 11, 20254 min read
UBC Launches New Pharmacovigilance Reporting Capabilities
UBC launches new RxLogix pharmacovigilance reporting platform to enhance drug safety capabilities with advanced aggregate reporting, real-time analytics, and reduced regulatory risk for biopharmaceutical companies.